Avitar EBITDA Margin 1971-1970 | AVTI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Avitar (AVTI) over the last 10 years. The current EBITDA margin for Avitar as of January 01, 1970 is .
Avitar EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.099B 21.51
Becton Dickinson (BDX) United States $52.271B 12.94
Cardinal Health (CAH) United States $37.565B 19.67
Straumann Holding AG (SAUHY) Switzerland $21.319B 0.00
West Pharmaceutical Services (WST) United States $18.188B 36.34
Align Technology (ALGN) United States $14.918B 29.61
Cooper (COO) United States $14.739B 19.00
Henry Schein (HSIC) United States $8.526B 14.62
Merit Medical Systems (MMSI) United States $4.898B 23.68
DENTSPLY SIRONA (XRAY) United States $3.211B 9.59
CONMED (CNMD) United States $1.556B 11.64
STAAR Surgical (STAA) United States $0.920B 0.00
Pro-Dex (PDEX) United States $0.168B 18.40
Lifevantage (LFVN) United States $0.163B 16.77